FYX Overview

• ETF Performance Analysis: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $128.61, indicating a potential upside of 17.17% from its current trading price of $109.76.

• Notable Holdings: Key underlying holdings with significant upside potential include Cipher Mining Inc (CIFR), Adaptive Biotechnologies Corp (ADPT), and Flywire Corp (FLYW), each showing expected price increases of 22.37%, 22.37%, and 20.28% respectively.

• Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they are based on outdated information.

• Investor Research Importance: It emphasizes the need for further investor research to assess the validity of analyst targets in light of recent company and industry developments.

• ETF Analyst Target Price: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $122.32, indicating a potential upside of 10.92% from its current trading price of $110.28.

• Notable Holdings with Upside: Key underlying holdings of FYX, such as Distribution Solutions Group Inc (DSGR), Clover Health Investments Corp (CLOV), and Vital Farms Inc (VITL), show significant upside potential based on analyst target prices, with expected increases of 23.32%, 21.67%, and 20.01% respectively.

• ETF Performance Analysis: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $121.97, indicating a potential upside of 12.46% from its current trading price of $108.45.

• Notable Holdings with Upside: Key underlying holdings such as Harrow Inc (HROW), Travere Therapeutics Inc (TVTX), and Omnicell Inc (OMCL) show significant upside potential, with target prices suggesting increases of 56.48%, 53.10%, and 39.49% respectively from their recent trading prices.

ETF Analysis Overview

• Implied Analyst Target Price for FYX: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $120.69 per unit, based on its underlying holdings.
• Current Trading Price and Upside Potential: FYX is currently trading at approximately $107.35 per unit, indicating a potential upside of 12.43% according to analyst targets.

Notable Holdings with Upside

• FormFactor Inc (FORM): Recent trading price is $29.19 per share, with an average analyst target of $34.62 per share, suggesting an upside of 18.62%.
• Quantum Computing Inc (QUBT): Currently trading at $15.79 per share, with a target price of $18.50 per share, indicating a potential upside of 17.20%.
• QCR Holdings Inc (QCRH): Recent price is $78.38 per share, while the average target price is $89.30 per share, reflecting an upside of 13.93%.

Analyst Target Justification

• Skepticism on Analyst Targets: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to potential downgrades if they are based on outdated information.
• Need for Further Research: Investors are encouraged to conduct additional research to assess the validity of these targets in light of recent company and industry developments.

• ETF Analyst Target Prices: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $115.39 per unit, indicating a potential upside of 14.09% from its recent trading price of $101.14.

• Stock Performance Insights: Notable underlying holdings such as MiMedx Group Inc, Core Scientific Inc, and Klaviyo Inc show significant upside potential based on analyst targets, with expected increases ranging from 34.46% to 76.99% above their current prices.

• ETF Analyst Target Prices: The First Trust Small Cap Core AlphaDEX Fund ETF (FYX) has an implied analyst target price of $114.51, indicating an 18.44% upside from its current trading price of $96.68 per unit.

• Notable Holdings with Upside Potential: Key underlying holdings like Rumble Inc, Helios Technologies Inc, and ICF International Inc show significant potential for growth, with expected price increases of 60.77%, 46.08%, and 35.55% respectively based on analyst targets.